EUVIMEDEUVIMED entdecken
Systematische Übersicht

Use of dipyrone during pregnancy and risk of congenital anomalies: a systematic review

Karine Duarte Curvello, Helana Ortiz Garcia, Tatiana da Silva Sempé, Raimunda Alyne Maciel Feitosa da Silva, Luana Giongo Pedrotti, Fernanda Sales Luiz Vianna, Tatiane da Silva Dal Pizzol

European Journal of Clinical Pharmacology · 2025

DOI: 10.1007/s00228-024-03769-4 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift European Journal of Clinical Pharmacology, 2025. Verfasst von Karine Duarte Curvello und 6 weiteren Autor:innen. Beteiligte Einrichtung: Programa de Pós-Graduação Em Assistência Farmacêutica, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil. Hauptthemen laut MEDLINE: Dipyrone, Abnormalities, Drug-Induced, Anti-Inflammatory Agents, Non-Steroidal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: This study aimed to summarize the evidence on the teratogenic effects of dipyrone used during pregnancy. METHODS: Databases (MEDLINE, EMBASE, Cochrane Library, CINAHL, Web of Science, Lilacs, SciELO, SCOPUS, OasisBR, and OpenGray) were reviewed until September 2023. We included studies that compared pregnant women who used dipyrone during any gestational period with those who used other analgesics or did not use any analgesics during the same gestational period. The outcome assessed was the presence of any congenital anomaly. Two reviewers independently conducted the review process, and a third reviewer resolved any disagreements. The risk of bias was assessed using the Joanna Briggs Institute tool for observational studies. The reviewed data synthesis is presented in narrative form. RESULTS: The search retrieved 2045 results, of which seven studies were included in the review, four were case‒control studies, and three were cohort studies involving 153,562 participants. The congenital anomalies evaluated varied across studies, with unspecified congenital anomalies predominating. Five of seven studies found no association between dipyrone and congenital anomalies. In a case‒control study, a positive association was found between dipyrone use and isolated congenital cataracts compared to two control groups; in another study, a positive association for unspecified congenital anomalies was observed in only one of the two control groups analyzed. In all studies, a high risk of bias was identified, especially regarding measuring the exposure, outcome, and assessment of confounding factors. CONCLUSION: There is not enough evidence to define the risk of congenital anomalies associated with dipyrone use during pregnancy. REGISTRATION: CRD 42022333041.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DipyroneAbnormalities, Drug-InducedAnti-Inflammatory Agents, Non-SteroidalHumansPregnancyFemaleCongenital Abnormalities

Stichwörter der Autor:innen

Congenital anomaliesDipyroneObservational studiesPregnancySystematic review

Substanzen

DipyroneAnti-Inflammatory Agents, Non-Steroidal

Autor:innen und Institutionen

  • Programa de Pós-Graduação Em Assistência Farmacêutica, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
  • Hospital Moinhos de Vento, Porto Alegre, RS, Brazil.
  • Instituto Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
  • Departamento de Genética, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
  • Laboratório de Medicina Genômica, Centro de Pesquisa Experimental, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil.
  • Programa de Pós-Graduação Em Assistência Farmacêutica, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil. tatiane.silva@ufrgs.br.

Zitieren

APA

Curvello, K. D., Garcia, H. O., da Silva Sempé, T., da Silva, R. A. M. F., Pedrotti, L. G., Vianna, F. S. L., & da Silva Dal Pizzol, T. (2025). Use of dipyrone during pregnancy and risk of congenital anomalies: a systematic review. European Journal of Clinical Pharmacology. https://doi.org/10.1007/s00228-024-03769-4

Vancouver

Curvello KD, Garcia HO, da Silva Sempé T, da Silva RAMF, Pedrotti LG, Vianna FSL, et al. Use of dipyrone during pregnancy and risk of congenital anomalies: a systematic review. European Journal of Clinical Pharmacology. 2025. doi:10.1007/s00228-024-03769-4

BibTeX
@article{Curvello2025,
  author = {Curvello, Karine Duarte and Garcia, Helana Ortiz and da Silva Sempé, Tatiana and da Silva, Raimunda Alyne Maciel Feitosa and Pedrotti, Luana Giongo and Vianna, Fernanda Sales Luiz and da Silva Dal Pizzol, Tatiane},
  title = {Use of dipyrone during pregnancy and risk of congenital anomalies: a systematic review},
  journal = {European Journal of Clinical Pharmacology},
  year = {2025},
  doi = {10.1007/s00228-024-03769-4}
}
Kostenlos starten →